These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 39027879)

  • 21. Use and Outcomes of Triple Antithrombotic Therapy with Non-Vitamin K Antagonists in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.
    Casamira N; García-Camarero T; Montoro-Ronsano JB; Veiga G; Del Blanco BG; De La Torre JM; Gordon B; García-Dorado D; Sambola A
    Am J Med Sci; 2019 Aug; 358(2):95-103. PubMed ID: 31176420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in patients with hypertrophic cardiomyopathy with non-valvular atrial fibrillation.
    Lin Y; Xiong H; Su J; Lin J; Zhou Q; Lin M; Zhao W; Peng F
    Heart Vessels; 2022 Jul; 37(7):1224-1231. PubMed ID: 35041061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and efficacy of NOAC vs. VKA in patients treated by PCI: a retrospective study of the FRANCE PCI registry.
    Durand E; Verrez T; Gillibert A; Levesque T; Barbe T; Koning R; Motreff P; Eltchaninoff H; Collet JP; Rangé G
    Front Cardiovasc Med; 2023; 10():1320001. PubMed ID: 38292452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct Oral Anticoagulants in the Treatment of Left Ventricular Thrombus: A Retrospective, Multicenter Study and Meta-Analysis of Existing Data.
    Cochran JM; Jia X; Kaczmarek J; Staggers KA; Rifai MA; Hamzeh IR; Birnbaum Y
    J Cardiovasc Pharmacol Ther; 2021 Mar; 26(2):173-178. PubMed ID: 33078629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct oral anticoagulants versus vitamin K antagonists for patients with left ventricular thrombus.
    Xu Z; Li X; Li X; Gao Y; Mi X
    Ann Palliat Med; 2021 Sep; 10(9):9427-9434. PubMed ID: 34628868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and Effectiveness of Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation and Anemia: A Retrospective Cohort Study.
    Wang CL; Wu VC; Huang YT; Kuo CF; Chu PH; Chen YL; Wen MS; Chang SH
    J Am Heart Assoc; 2019 May; 8(9):e012029. PubMed ID: 31020896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants.
    Pastori D; Lip GYH; Farcomeni A; Del Sole F; Sciacqua A; Perticone F; Marcucci R; Grifoni E; Pignatelli P; Violi F;
    Int J Cardiol; 2018 Aug; 264():58-63. PubMed ID: 29776574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of bleeding and arterial thromboembolism in patients with non-valvular atrial fibrillation either maintained on a vitamin K antagonist or switched to a non-vitamin K-antagonist oral anticoagulant: a retrospective, matched-cohort study.
    Bouillon K; Bertrand M; Maura G; Blotière PO; Ricordeau P; Zureik M
    Lancet Haematol; 2015 Apr; 2(4):e150-9. PubMed ID: 26687957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct oral anticoagulants compared to vitamin K antagonist for the management of left ventricular thrombus.
    Iqbal H; Straw S; Craven TP; Stirling K; Wheatcroft SB; Witte KK
    ESC Heart Fail; 2020 Oct; 7(5):2032-2041. PubMed ID: 32583975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rationale and design of a prospective multi-center randomized trial of EARLY treatment by rivaroxaban versus warfarin in ST-segment elevation MYOcardial infarction with Left Ventricular Thrombus (EARLY-MYO-LVT trial).
    He J; Ge H; Dong JX; Zhang W; Kong LC; Qiao ZQ; Zheng Y; Ding S; Wan F; Shen L; Wang W; Gu ZC; Yang F; Li Z; Pu J
    Ann Transl Med; 2020 Mar; 8(6):392. PubMed ID: 32355836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Characteristics And Health Care Resources In Patients Treated With Oral Anticoagulants: Evidences From Italian Administrative Databases.
    Degli Esposti L; Andretta M; Di Pasquale G; Gambera M; Saragoni S; Perrone V; Buda S
    Vasc Health Risk Manag; 2019; 15():429-437. PubMed ID: 31632047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meta-analysis of the safety and efficacy of using minimally interrupted novel oral anticoagulants in patients undergoing catheter ablation for atrial fibrillation.
    Mao YJ; Wang H; Huang PF
    J Interv Card Electrophysiol; 2021 Apr; 60(3):407-417. PubMed ID: 32361948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapy persistence in newly diagnosed non-valvular atrial fibrillation treated with warfarin or NOAC. A cohort study.
    Martinez C; Katholing A; Wallenhorst C; Freedman SB
    Thromb Haemost; 2016 Jan; 115(1):31-9. PubMed ID: 26246112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of Major Bleeding in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice (from Phase II of the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF II]).
    Steinberg BA; Simon DN; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Kowey PR; Mahaffey KW; Peterson ED; Piccini JP;
    Am J Cardiol; 2017 May; 119(10):1590-1595. PubMed ID: 28363354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bleeding complications with oral anticoagulants in the elderly: an observational study.
    Peeterbroeck J; Danguy C; Lelubre C; Meulemans M; Higuet S
    Geriatr Psychol Neuropsychiatr Vieil; 2016 Dec; 14(4):406-412. PubMed ID: 27507064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quality of life and patient satisfaction in patients with atrial fibrillation on stable vitamin K antagonist treatment or switched to a non-vitamin K antagonist oral anticoagulant during a 1-year follow-up: A PREFER in AF Registry substudy.
    De Caterina R; Brüggenjürgen B; Darius H; Köhler S; Lucerna M; Pecen L; Renda G; Schilling RJ; Schliephacke T; Zamorano JL; Le Heuzey JY; Kirchhof P
    Arch Cardiovasc Dis; 2018 Feb; 111(2):74-84. PubMed ID: 28942115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recanalization therapies in acute ischemic stroke patients: impact of prior treatment with novel oral anticoagulants on bleeding complications and outcome.
    Seiffge DJ; Hooff RJ; Nolte CH; Béjot Y; Turc G; Ikenberg B; Berge E; Persike M; Dequatre-Ponchelle N; Strbian D; Pfeilschifter W; Zini A; Tveiten A; Næss H; Michel P; Sztajzel R; Luft A; Gensicke H; Traenka C; Hert L; Scheitz JF; De Marchis GM; Bonati LH; Peters N; Charidimou A; Werring DJ; Palm F; Reinhard M; Niesen WD; Nagao T; Pezzini A; Caso V; Nederkoorn PJ; Kägi G; von Hessling A; Padjen V; Cordonnier C; Erdur H; Lyrer PA; Brouns R; Steiner T; Tatlisumak T; Engelter ST;
    Circulation; 2015 Sep; 132(13):1261-9. PubMed ID: 26232277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of direct oral anticoagulants for treatment of left ventricular thrombus; a systematic review.
    Kumar D; Warsha FNU; Helmstetter N; Gupta V
    Acta Cardiol; 2021 Oct; 76(8):825-829. PubMed ID: 33970796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Efficacy and safety of non-vitamin K antagonist versus vitamin K antagonist oral anticoagulants in the prevention and treatment of thrombotic disease in active cancer patients: a systematic review and meta-analysis of randomized controlled trials].
    Wang CX; Wu D; Yang PP; Wu QH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Aug; 48(8):689-696. PubMed ID: 32847326
    [No Abstract]   [Full Text] [Related]  

  • 40. Oral anticoagulation patterns and prognosis in octogenarian patients with atrial fibrillation.
    Papanastasiou A; Kartas A; Samaras A; Vrana E; Papazoglou A; Moysidis DV; Baroutidou A; Botis M; Liampas E; Vouloagkas I; Mareti E; Karagiannidis E; Karvounis H; Tzikas A; Giannakoulas G
    J Thromb Thrombolysis; 2022 May; 53(4):851-860. PubMed ID: 34562201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.